3.35

3.72% 0.12

After Hours: 3.40 0.05 +1.49%

Endra Life Sciences Inc (NDRA)

Overview News Price History Financials Discussions Forecast Stock Split

Endra Life Sciences Inc stock is traded at $3.35, with a volume of 52,170. It is up +3.72% in the last 24 hours and down -44.17% over the past month. ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Previous Close:

$3.23

Open:

$3.23

24h Volume:

52,170

Relative Volume:

0.33

Market Cap:

$2.48M

Revenue:

Net Income/Loss:

$-8.82M

P/E Ratio:

-0.00485

EPS:

-691.4213

Net Cash Flow:

$-8.08M

1W Performance:

+7.72%

1M Performance:

-44.17%

6M Performance:

-41.33%

1Y Performance:

-99.32%

1-Day Range:

$3.23

$3.4645

1-Week Range:

$2.915

$3.4645

52-Week Range:

$2.90

$542.50

Endra Life Sciences Inc Stock (NDRA) Company Profile

Name

Endra Life Sciences Inc

Sector

Healthcare (1170)

Industry

Diagnostics & Research (56)

Phone

734-335-0468

Address

3600 GREEN COURT, ANN ARBOR, MI

Employee

Twitter

@endralifesci

Next Earnings Date

2024-11-12

Latest SEC Filings

NDRA's Discussions on Twitter

Compare NDRA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NDRA Endra Life Sciences Inc	3.35	2.30M	0	-8.82M	-8.08M	-691.42
TMO Thermo Fisher Scientific Inc	402.82	148.60B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	189.90	132.07B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	513.36	40.34B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	111.92	30.82B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	140.33	23.70B	15.50B	1.33B	2.16B	7.34

Endra Life Sciences Inc Stock (NDRA) Latest News

May 30, 2025

Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus

May 30, 2025

Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 30, 2025

ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus

May 15, 2025

ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView

May 15, 2025

ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView

May 15, 2025

ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025

Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks

May 15, 2025

ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com

May 15, 2025

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan

May 15, 2025

May 11, 2025

ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 03, 2025

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter

May 03, 2025

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World

May 03, 2025

Apr 28, 2025